Showing results (91-100 of 126) with videos related to
Sort By:
Pageof 13
Journal of Robotic Surgery|September 16, 2016
Robotic radical hysterectomy: comparison of outcomes and costDarron Halliday, Susie Lau, Zvi Vaknin, et al.BMC Medicine|September 11, 2015
Chemotherapy reduces PARP1 in cancers of the ovary: implications for future clinical trials involving PARP inhibitorsMaud Marques, Marie-Claude Beauchamp, Hubert Fleury, et al.Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|June 8, 2012
Combination of serum biomarkers to differentiate malignant from benign ovarian tumoursGang He, Christina A Holcroft, Marie-Claude Beauchamp, et al.Cancer Genetics and Cytogenetics|September 24, 2004
Genomic analyses of primary and metastatic serous epithelial ovarian cancerOfir Israeli, Walter H Gotlieb, Eitan Friedman, et al.BMC Cancer|September 10, 2017
Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitorsCharles-André Philip, Ido Laskov, Marie-Claude Beauchamp, et al.Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|May 13, 2021
Sentinel Lymph Node Sampling as an Alternative to Lymphadenectomy in Patients With Endometrial Cancer and ObesityEmad Matanes, Neta Eisenberg, Zainab Amajoud, et al.Gynecologic Oncology|July 25, 2017
Dose dense carboplatin paclitaxel improves progression free survival in patients with endometrial cancerLiron Kogan, Ido Laskov, Zainab Amajoud, et al.Journal of Surgical Oncology|July 12, 2022
Predicting recurrence and recurrence-free survival in high-grade endometrial cancer using machine learningSabrina Piedimonte, Tomer Feigenberg, Erik Drysdale, et al.Gynecologic Oncology Reports|June 20, 2018
Impact of lower uterine segment involvement in type II endometrial cancer and the unique mutational profile of serous tumorsLiron Kogan, David Octeau, Zainab Amajoud, et al.Journal of Surgical Oncology|April 16, 2020
The impact of wait times on oncological outcome in high-risk patients with endometrial cancerCristina Mitric, Emad Matanes, Michel Wissing, et al.Pageof 13